Train from scratch? Build upon open source? Leverage frontier models? In this episode, Dov Gertz (Cofounder and CEO) explains how Converge Bio is developing the most cutting-edge Generative AI models for Bioscience as the technology promises to transform the Life Sciences industry as we know it.
00:00 - Series AI Intro
00:40 -Pharma Industry and Converge Team Overview
05:00 - Empowering the Life Science Industry with Foundation Models
08:30 - The Landscape of Open and Proprietary Bioscience AI Models
13:37 - Why Scientific Rigor, and Transparency, is Essential
17:55 - Pharma's Rapid AI Adoption Curve
25:17 - How AI Fundamentally Alters the Business of Pharma
31:40 - Evolving Ahead of the Market
34:20 - Outro